% | $
Quotes you view appear here for quick access.

Hospira Inc. Message Board

recombinantman 3 posts  |  Last Activity: May 17, 2016 4:42 PM Member since: Feb 1, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to


    by wilburjh1 May 17, 2016 10:04 AM
    recombinantman recombinantman May 17, 2016 4:42 PM Flag

    The decision on Coherus's request can not take more than 12 months according to the IPR rules. If the decision is unfavorable to Abbvie, Abbvie could appeal the decision and delay competition by up to another 12 months. So, probably no immediate competition to Humira, but something to watch. Today was an excellent day to close out previously sold calls for a nice profit and buy calls at a cheap price. Abbvie is a great trading stock and the dividend, which was received today, is also great. Lots to love about Abbvie.

  • recombinantman by recombinantman Apr 11, 2016 8:27 AM Flag

    RBC increased Abt price target today to 48 from 45. May see a price increase today.

  • Reply to

    Pfizer etc looking to buy

    by hipthreevet Apr 7, 2016 9:07 AM
    recombinantman recombinantman Apr 7, 2016 5:39 PM Flag

    Why? Abbv has high debt, main product comes off patent 12/16, unknown whether Humira patents will fend off biosimilars and an attractive, but unproven pipeline.